Measurement-based care for unipolar depression

Current Psychiatry Reports

Volumn 13, Issue 6, 2011, Pages 446-458

  Morris, David W ^a   Trivedi, Madhukar H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adherence; Antidepressant treatment; Depression; Major depressive disorder; Measurement based care; Medication tolerability; Safety; Treatment algorithm; Treatment guidelines; Treatment emergent symptoms; Unipolar depression

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DESVENLAFAXINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; ISOCARBOXAZID; MAPROTILINE; MIRTAZAPINE; NOMIFENSINE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRIMIPRAMINE; UNINDEXED DRUG; VENLAFAXINE;

16 ITEM QUICK INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY CLINICIAN RATED; 16 ITEM QUICK INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY PATIENT SELF REPORT; ARTICLE; BECK DEPRESSION INVENTORY; CARROLL RATING SCALE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; DEPRESSIVE SYMPTOMATOLOGY CLINICIAN RATED; DISEASE SEVERITY; DRUG CHOICE; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HAMILTON SCALE; HEALTH CARE DELIVERY; HUMAN; MAJOR DEPRESSION; MEASUREMENT BASED CARE; MEDICAL DECISION MAKING; MEDICAL HISTORY; MEDICAL INFORMATION SYSTEM; MEDICATION THERAPY MANAGEMENT; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT HEALTH QUESTIONNAIRE 9; PATIENT MONITORING; PRACTICE GUIDELINE; PSYCHOLOGICAL RATING SCALE; RISK BENEFIT ANALYSIS; SELF REPORT; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; TREATMENT DURATION; TREATMENT RESPONSE; ZUNG DEPRESSION RATING SCALE; DEPRESSION; METHODOLOGY; QUESTIONNAIRE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; MEDICATION ADHERENCE; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES;

EID: 84855906965     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-011-0237-8     Document Type: Article

References (50)

1. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA. 1995;273:1026-31.
2. Kessler RC, Berglund, Demler O, et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-105. (Pubitemid 37432885)
3. Simon GE, VonKorff M, Wagner EH, Barlow W. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry. 1993;15:399-408. (Pubitemid 24006273)
4. Trivedi MH, Kern JK, Grannemann BD, et al. A computerized clinical decision support system as a means of implementing depression guidelines. Psychiatr Serv. 2004;55:879-85. (Pubitemid 39025214)
5. Trivedi MH, Kleiber BA. Using treatment algorithms for the effective management of treatment-resistant depression. J Clin Psychiatry. 2001;62:25-9. (Pubitemid 33736202)
6. Ford DE. Managing patients with depression: Is primary care up to the challenge? J Gen Intern Med. 2000;15:344-5. (Pubitemid 30333832)
7. Lin EHB, Von Korff M, Katon W, et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care. 1995;33:67-74.
8. Trivedi MH, Baker SM. Clinical significance of monitoring early symptom change to predict outcome. J Clin Psychiatry. 2001;62 (S4):27-33. (Pubitemid 32183562)
9. Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354:1243-52.
10. Biggs MM, Shores-Wilson K, Rush AJ, et al. A comparison of alternative assessments of depressive symptom severity: A pilot study. Psychiatry Res. 2000;96:269-79.
11. Trivedi MH, Rush AJ, Gaynes BN, et al. Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care. Neuropsychopharmacology. 2007;32:2479-89. (Pubitemid 350126843)
12. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurementbased care in STAR*D: Implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. (Pubitemid 43050100)
13. Rush AJ, Trivedi MH, Stewart JW, et al. Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry 2011, 168:689-701. This article details the use of ADM MBC in patients with chronic and/or recurrent depression. The screening process, treatment selection, and medication management of patients using ADM MBC to manage medication combinations from the onset of treatment are outlined.
14. Morris DW, Trivedi MH, Husain MM, et al. Indicators of pretreatment suicidal ideation in adults with major depressive disorder. Acta Psychiatrica Scandinavica. 2010;121:480-4.
15. Trivedi MH, Kocsis JH, Thase ME, et al. REVAMP-research evaluating the value of augmenting medication with psychotherapy: Rationale and design. Psychopharmacol Bull 2008, 41(4):5-33. This article details the use of ADM MBC in patients with chronic depression. The treatment selection process and use of ADM MBC in treating patients with initial monotherapy, followed by augmentation for partial response and a medication switch for nonresponse are outlined.
16. Rush AJ, Crismon ML, Kashner TM, et al. Texas medication algorithm project, phase 3 (TMAP-3): Rationale and study design. J Clin Psychiatry. 2003;64:357-69. (Pubitemid 36547277)
17. Trivedi MH, Rush AJ, Crismon ML, et al. Clinical results for the patient with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry. 2004;61:669-79.
18. Trivedi MH, Wisniewski SR, Morris DW, et al. Concise Associated Symptoms Tracking scale: A brief self-report and clinician rating of symptoms associated with suicidality. J Clin Psychiatry 2011, 72(6):765-74. This article details a self-report safety measure (CAST) developed to evaluate psychiatric symptoms of the "activation syndrome" believed to be associated with treatment-emergent suicidal thoughts and behaviors.
19. Trivedi MH, Wisniewski SR, Morris DW, et al. Concise Health Risk Tracking scale: A brief self-report and clinician rating of suicidal risk. J Clin Psychiatry 2011, 72(6):757-64. This article introduces a safety measure developed to screen for and evaluate treatment-emergent suicidal ideation, behavior, and related features. The CHRT and CAST have been used as safety measures in the ADM MBC treatment algorithms.
20. Hamilton M. A rating scale for depression. J Neurology Neurosurgery Psychiatry. 1960;23:56-62.
21. Mongomery SA, Asberg MA. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-9.
22. Rush AJ, Giles DE, Schlesser MA, et al. The inventory of depressive symptomatology (IDS): Preliminary findings. Psychiatry Res. 1986;18:65-87. (Pubitemid 16085767)
23. Rush AJ, Gullion CM, Basco MR, et al. The Inventory of Depressive Symptomatology (IDS): Psychometric properties. Psychological Medicine. 1996;26:477-86. (Pubitemid 26142491)
24. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-item Quick Inventory of Depressive Symptomatology (QIDS) Clinician Rating (QIDS-C) and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry. 2003;54:573-83. (Pubitemid 37289444)
25. Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self- Report (IDS-SR), the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation. Psychological Medicine. 2004;34:73-82. (Pubitemid 38139442)
26. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Archives Gen Psychiatry. 1961;4:561-71.
27. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of beck depression inventories IA and II in psychiatric outpatients. J Personality Assessment. 1996;67(3):588-97. (Pubitemid 26382973)
28. Zung WWK. A self-rating depression scale. Archives Gen Psychiatry. 1965;12:63-70.
29. Carroll BJ, Feinberg M, Smouse PE, et al. The carroll rating scale for depression, 1: Development, reliability and validity. Br J Psychiatry. 1981;138:194-209.
30. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression measure. J Gen Intern Med. 2001;16:603-13.
31. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1(3):385-401.
32. Wisniewski SR, Rush AJ, Balasubramani GK, et al. A self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract. 2006;12(2):71-9. (Pubitemid 44284089)
33. Levine J, Schooler NR. SAFTEE: A technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull. 1986;22(2):343-81. (Pubitemid 16043808)
34. Moynihan R. FDA advisory panel calls for suicide warnings over new antidepressants. BMJ. 2004;328(7435):303.
35. Mann JJ, Kapur S. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Arch Gen Psychiatry. 1991;48(11):1027-33.
36. Food and Drug Administration: Labeling change request letter for antidepressant medications. Available at http://www.fda.gov.cder/ drug/antidepressants/SSRIlabelChange.htm. Last updated: 2003; Accessed December 9, 2005.
37. Posner K, Oquendo MA, Gould M, et al. Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007;164:1035-43. (Pubitemid 47121392)
38. Rush AJ, Kraemer HC, Sackeim HA, et al. Report by the ACNP task force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31(9):1841-53.
39. Hirschfeld RM, Dunner DL, Keitner G, et al. Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry. 2002;51(2):123-33. (Pubitemid 34127902)
40. Fava GA, Fabbri S, Sonino N. Residual symptoms in depression: An emerging therapeutic target. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(6):1019-27. (Pubitemid 35256092)
41. Judd LL, Paulus MP, Zeller P. The role of residual subthreshold depressive symptoms in early episode relapse in unipolar major depressive disorder. Arch Gen Psychiatry. 1999;56(8):764-5. (Pubitemid 29357740)
42. Paykel ES, Ramana R, Cooper Z, et al. Residual symptoms after partial remission: An important outcome in depression. Psychol Med. 1995;25:1171-80.
43. Thase ME, Simons AD, McGeary J, et al. Relapse after cognitive behavior therapy of depression: Potential implications for longer courses of treatment. Am J Psychiatry. 1992;149:1046-52.
44. Prien RF, Kupfer DJ. Continuation drug therapy for major depressive episodes: How long should it be maintained? Am J Psychiatry. 1986;143:18-23. (Pubitemid 16185856)
45. Harding KJ, Rush AJ, Arbuckle M et al. Measurement-based care in psychiatric practice: A policy framework for implementation. J Clin Psychiatry 2011, 72(8):1136-1143. This article describes the strengths and weaknesses of MBC and provides a top 10 list for the implementation of MBC into standard clinical practice.
46. Kurian BT, Trivedi MH, Grannemann BD, et al. A computerized decision support system for depression in primary care. Prim Care Companion J Clin Psychiatry. 2009;11(4):140-6.
47. Litzelman DK, Dittus RS, Miller ME, Tierney WM. Requiring physicians to respond to computerized reminders improves their compliance with preventive care protocols. J Gen Intern Med. 1993;8:311-7. (Pubitemid 23177844)
48. Margolis CZ, Warshawsky SS, Goldman L, et al. Computerized algorithms and pediatricians' management of common problems in a community clinic. Acad Med. 1992;67:282-4.
49. McDonald CJ, Hui SL, Smith DM, Tierney WM, Cohen SJ, Weinberger M, et al. Reminders to physicians from an introspective computer medical record. A two-year randomized trial. Ann Intern Med. 1984;100:130-8. (Pubitemid 14219142)
50. Tierney WM, Overhage JM, Takesue BY, Harris LE, Murray MD, Vargo DL, et al. Computerizing guidelines to improve care and patient outcomes: The example of heart failure. J Am Med Inform Assoc. 1995;1995(2):316-22.